150 related articles for article (PubMed ID: 2941730)
21. Enzyme studies in GM2 gangliosidiosis, and their application in prenatal diagnosis.
Kaur M; Verma IC
Indian J Pediatr; 1995; 62(4):485-9. PubMed ID: 10829910
[TBL] [Abstract][Full Text] [Related]
22. First trimester prenatal diagnosis of Tay-Sachs disease using the sulfated synthetic substrate for hexosaminidase A.
Callahan JW; Archibald A; Skomorowski MA; Shuman C; Clarke JT
Clin Biochem; 1990 Dec; 23(6):533-6. PubMed ID: 2149678
[TBL] [Abstract][Full Text] [Related]
23. Identification of candidate active site residues in lysosomal beta-hexosaminidase A.
Fernandes MJ; Yew S; Leclerc D; Henrissat B; Vorgias CE; Gravel RA; Hechtman P; Kaplan F
J Biol Chem; 1997 Jan; 272(2):814-20. PubMed ID: 8995368
[TBL] [Abstract][Full Text] [Related]
24. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
Hechtman P; Boulay B; Bayleran J; Andermann E
Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: Tay-Sachs and Sandhoff diseases.
Maret A; Salvayre R; Negre A; Bes JC; Douste-Blazy L
Biol Cell; 1985; 53(3):293-6. PubMed ID: 2990625
[TBL] [Abstract][Full Text] [Related]
26. An altered hexosaminidase A in the liver affected by Hurler and Hunter syndromes.
Minami R; Nakamura F; Kudoh T; Oyanagi K; Nakao T
Tohoku J Exp Med; 1980 Nov; 132(3):329-35. PubMed ID: 6451055
[TBL] [Abstract][Full Text] [Related]
27. Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer.
Akli S; Guidotti JE; Vigne E; Perricaudet M; Sandhoff K; Kahn A; Poenaru L
Gene Ther; 1996 Sep; 3(9):769-74. PubMed ID: 8875224
[TBL] [Abstract][Full Text] [Related]
28. Adult GM2 gangliosidosis in association with Tay-Sachs disease: a new phenotype.
Navon R; Argov Z; Brand N; Sandbank U
Neurology; 1981 Nov; 31(11):1397-1401. PubMed ID: 6458776
[No Abstract] [Full Text] [Related]
29. Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients.
Bayleran J; Hechtman P; Kolodny E; Kaback M
Am J Hum Genet; 1987 Oct; 41(4):532-48. PubMed ID: 2959149
[TBL] [Abstract][Full Text] [Related]
30. Hexosaminidase A deficiency in adults.
Navon R; Argov Z; Frisch A
Am J Med Genet; 1986 May; 24(1):179-96. PubMed ID: 2939718
[TBL] [Abstract][Full Text] [Related]
31. W474C amino acid substitution affects early processing of the alpha-subunit of beta-hexosaminidase A and is associated with subacute G(M2) gangliosidosis.
Petroulakis E; Cao Z; Clarke JT; Mahuran DJ; Lee G; Triggs-Raine B
Hum Mutat; 1998; 11(6):432-42. PubMed ID: 9603435
[TBL] [Abstract][Full Text] [Related]
32. Estimation of the frequency of hexosaminidase a variant alleles in the American Jewish population.
Greenberg DA; Kaback MM
Am J Hum Genet; 1982 May; 34(3):444-51. PubMed ID: 6211091
[TBL] [Abstract][Full Text] [Related]
33. Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activity.
Charrow J; Inui K; Wenger DA
Clin Genet; 1985 Jan; 27(1):78-84. PubMed ID: 3156697
[TBL] [Abstract][Full Text] [Related]
34. Enzyme immunoassay of beta-hexosaminidase A and B in serum: carrier detection of GM2-gangliosidoses, and equivalence of enzyme activity and enzyme protein reactivity.
Isaksson A; Hultberg B; Masson P; Landels E; Fensom A
Clin Chem; 1993 Jul; 39(7):1412-5. PubMed ID: 8330398
[TBL] [Abstract][Full Text] [Related]
35. Unusual thermolability properties of beta-hexosaminidase: studies of enzyme from cultured cells and clinical implications.
Prence EM; Zalewski I; Natowicz MR
Am J Med Genet; 1996 Nov; 65(4):320-4. PubMed ID: 8923943
[TBL] [Abstract][Full Text] [Related]
36. Prenatal diagnosis of GM2-gangliosidosis B1 variant.
Lemos M; Pinto R; Ribeiro G; Ribeiro H; Lopes L; Sá Miranda MC
Prenat Diagn; 1995 Jun; 15(6):585-8. PubMed ID: 7659693
[TBL] [Abstract][Full Text] [Related]
37. Unusual thermolability properties of leukocyte beta-hexosaminidase: implications in screening for carriers of Tay-Sachs disease.
Prence EM; Natowicz MR; Zalewski I
Clin Chem; 1993 Sep; 39(9):1811-4. PubMed ID: 8375052
[TBL] [Abstract][Full Text] [Related]
38. Tay-Sachs disease heterozygote detection in Brazil: comparison between tears and leukocytes as beta-hexosaminidase A source.
Buchalter MS; Wannmacher CM; Wajner M
J Inherit Metab Dis; 1984; 7(1):35-7. PubMed ID: 6234430
[TBL] [Abstract][Full Text] [Related]
39. Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
Vallance H; Morris TJ; Coulter-Mackie M; Lim-Steele J; Kaback M
Mol Genet Metab; 2006 Feb; 87(2):122-7. PubMed ID: 16352452
[TBL] [Abstract][Full Text] [Related]
40. First-trimester prenatal diagnosis of Tay-Sachs disease.
Grabowski GA; Kruse JR; Goldberg JD; Chockkalingam K; Gordon RE; Blakemore KJ; Mahoney MJ; Desnick RJ
Am J Hum Genet; 1984 Nov; 36(6):1369-78. PubMed ID: 6240199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
